Impulsiveness, overactivity, and poorer sustained attention improve by chronic treatment with low doses of l-amphetamine in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD)

Behavioral and Brain Functions

Volumn 7, Issue , 2011, Pages

  Sagvolden, Terje ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CONTROLLED STUDY; IMPULSIVENESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TASK PERFORMANCE; VISUAL DISCRIMINATION; WISTAR KYOTO RAT; ANIMAL; ATTENTION; DISEASE MODEL; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECT; DRUG SCREENING; HYPERKINESIA; PSYCHOLOGICAL ASPECT;

AMPHETAMINE; ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; HYPERKINESIS; IMPULSIVE BEHAVIOR; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 79955512904     PISSN: None     EISSN: 17449081     Source Type: Journal    
DOI: 10.1186/1744-9081-7-6     Document Type: Article

References (35)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV 1994, Washington, D.C.: Author, 4, American Psychiatric Association.
2. Sagvolden T, Archer T. Future perspectives on ADD research -- An irresistible challenge. Attention deficit disorder: Clinical and basic research 1989, 369-389. Hillsdale, N.J.: Lawrence Erlbaum Associates, Sagvolden T, Archer T.
3. Johansen EB, Aase H, Meyer A, Sagvolden T. Attention-deficit/hyperactivity disorder (ADHD) behaviour explained by dysfunctioning reinforcement and extinction processes. Behav Brain Res 2002, 130:37-45. 10.1016/S0166-4328(01)00434-X, 11864716.
4. Sagvolden T, Johansen EB, Aase H, Russell VA. A dynamic developmental theory of Attention-Deficit/Hyperactivity Disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 2005, 28:397-419. 10.1017/S0140525X05000075, 16209748.
5. Johansen EB, Sagvolden T, Aase H, Russell VA. The dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD): Present status and future perspectives. Behav Brain Sci 2005, 28:451-454.
6. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997, 121:65-94. 10.1037/0033-2909.121.1.65, 9000892.
7. Tannock R. Attention deficit hyperactivity disorder: advances in cognitive, neurobiological, and genetic research. J Child Psychol Psychiatry 1998, 39:65-99. 10.1017/S0021963097001777, 9534087.
8. Arnsten AF, Dudley AG. Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 2005, 1:2. 10.1186/1744-9081-1-2, 1143775, 15916700.
9. Russell VA, Sagvolden T, Johansen EB. Animal models of attention-deficit hyperactivity disorder. Behav Brain Funct 2005, 1:9. 10.1186/1744-9081-1-9, 1180819, 16022733.
10. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 1998, 18:5901-5907.
11. Arnsten AFT, Li BM. Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions. Biol Psychiatry 2005, 57:1377-1384. 10.1016/j.biopsych.2004.08.019, 15950011.
12. Biederman J, Spencer T, Wilens T. Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder. Int J Neuropharmacol 2004, 7:77-97.
13. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry 2004, 13:102-116.
14. Grund T, Lehmann K, Bock N, Rothenberger A, Teuchert-Noodt G. Influence of methylphenidate on brain development - an update of recent animal experiments. Behav Brain Funct 2006, 2:2. 10.1186/1744-9081-2-2, 1363724, 16403217.
15. Conners CK. Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder. J Atten Disord 2002, 6(Suppl 1):S17-S30.
16. Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997, 54:857-864.
17. Schachar R, Jadad AR, Gauld M, Boyle M, Booker L, Snider A, et al. Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Can J Psychiatry 2002, 47:337-348.
18. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003, 111:179-185. 10.1542/peds.111.1.179, 12509574.
19. Sagvolden T. The spontaneously hypertensive rat as a model of ADHD. Stimulant drugs and ADHD: Basic and clinical neuroscience 2001, 221-237. New York: Oxford University Press, Solanto MV, Arnsten AFT, Castellanos FX.
20. Sagvolden T. Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD). Neurosci Biobehav Rev 2000, 24:31-39. 10.1016/S0149-7634(99)00058-5, 10654658.
21. Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1239-1247. 10.1016/j.biopsych.2005.02.002, 15949994.
22. Sagvolden T, Xu T. l-Amphetamine improves poor sustained attention while d-amphetamine reduces overactivity and impulsiveness as well as improves sustained attention in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). Behav Brain Funct 2008, 4.
23. Sagvolden T, Metzger MA, Schiørbeck HK, Rugland AL, Spinnangr I, Sagvolden G. The spontaneously hypertensive rat (SHR) as an animal model of childhood hyperactivity (ADHD): changed reactivity to reinforcers and to psychomotor stimulants. Behav Neural Biol 1992, 58:103-112. 10.1016/0163-1047(92)90315-U, 1360797.
24. Sagvolden T. The alpha-2A adrenoceptor agonist guanfacine improves sustained attention and reduces overactivity and impulsiveness in an animal model of Attention-Deficit/Hyperactivity Disorder (ADHD). Behav Brain Funct 2006, 2:41. 10.1186/1744-9081-2-41, 1764416, 17173664.
25. Wultz B, Sagvolden T, Moser EI, Moser MB. The spontaneously hypertensive rat as an animal model of attention-deficit hyperactivity disorder: effects of methylphenidate on exploratory behavior. Behav Neural Biol 1990, 53:88-102. 10.1016/0163-1047(90)90848-Z, 2302145.
26. Catania AC. Learning 1998, N.J., Englewoods Cliffs: Prentice Hall, 4.
27. Catania AC, Reynolds GS. A quantitative analysis of the responding maintained by interval schedules of reinforcement. J Exp Anal Behav 1968, 11(Suppl:327-Suppl):383.
28. StatSoft Statistica for Windows. [7.1]. 2005, Tulsa, OK: StatSoft, Inc., Ref Type: Computer Program, StatSoft.
29. Sleator EK, Ullman RK. Can a physician diagnose hyperactivity in the office?. Pediatrics 1981, 67:13-17.
30. Sagvolden T, Aase H, Zeiner P, Berger DF. Altered reinforcement mechanisms in Attention-Deficit/Hyperactivity Disorder. Behav Brain Res 1998, 94:61-71. 10.1016/S0166-4328(97)00170-8, 9708840.
31. Aase H, Sagvolden T. Infrequent, but not frequent, reinforcers produce more variable responding and deficient sustained attention in young children with attention-deficit/hyperactivity disorder (ADHD). J Child Psychol Psychiatry 2006, 47:457-471. 10.1111/j.1469-7610.2005.01468.x, 16671929.
32. Aase H, Sagvolden T. Moment-to-moment dynamics of ADHD behaviour. Behav Brain Funct 2005, 1:12. 10.1186/1744-9081-1-12, 1208851, 16060963.
33. Aase H, Meyer A, Sagvolden T. Moment-to-moment dynamics of ADHD behaviour in South African children. Behav Brain Funct 2006, 2:11. 10.1186/1744-9081-2-11, 1489933, 16569228.
34. Sagvolden T, Wultz B, Moser EI, Moser MB, Mørkrid L. Results from a comparative neuropsychological research program indicate altered reinforcement mechanisms in children with ADD. Attention deficit disorder: Clinical and basic research 1989, 261-286. Hillsdale, N.J.: Lawrence Erlbaum Associates, Sagvolden T, Archer T.
35. Sagvolden T, Sergeant JA. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour. Behav Brain Res 1998, 94:1-10. 10.1016/S0166-4328(97)00170-8, 9708834.